Barrett & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Barrett & Company's BMY Position: Q3 2026 in Review
Barrett & Company increased its Bristol-Myers Squibb (BMY) stake by 9.2% in Q3 2026, buying an estimated $32K and bringing the position to 5,999 shares worth $374K. The position accounts for 0.1% of the portfolio, ranked #109.
Barrett & Company first reported a position in BMY in Q3 2022 and has held it in 17 quarters since. The position peaked at $988K in Q4 2022. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Barrett & Company held 5,999 shares of Bristol-Myers Squibb worth $374K as of Q3 2026.
- Barrett & Company bought 506 Bristol-Myers Squibb shares in Q3 2026, an estimated $32K.
- Bristol-Myers Squibb made up 0.1% of Barrett & Company's portfolio in Q3 2026, its #109 holding.
- Barrett & Company first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 17 quarters since.
- Barrett & Company's Bristol-Myers Squibb position peaked at $988K in Q4 2022.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.